Jehangir Clinical Developement Centre Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-12-2024
- Paid Up Capital ₹ 1.25 M
as on 16-12-2024
- Company Age 18 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.75 Cr
as on 16-12-2024
- Revenue 68.71%
(FY 2022)
- Profit 56.14%
(FY 2022)
- Ebitda 114.07%
(FY 2022)
- Net Worth 25.01%
(FY 2022)
- Total Assets 95.14%
(FY 2022)
About Jehangir Clinical Developement Centre
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.25 M.
The company currently has active open charges totaling ₹3.75 Cr.
Jehangir Jehangir, Uma Divate, Pathik Divate, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85110PN2006PTC128975
- Company No.
128975
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Aug 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Jehangir Clinical Developement Centre Private Limited offer?
Jehangir Clinical Developement Centre Private Limited offers a wide range of products and services, including Copywriting & Content Development, Content Writing Service, Diagnostic Imaging & Pathology Labs, Medical Test Services.
Who are the key members and board of directors at Jehangir Clinical Developement Centre?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Uma Divate  | Director | 29-Aug-2006 | Current |
| Pathik Divate | Director | 31-Jan-2007 | Current |
| Cowasji Jehangir | Director | 25-Nov-2020 | Current |
| Jehangir Jehangir | Director | 29-Aug-2006 | Current |
| Geeta Divate | Director | 25-Nov-2020 | Current |
Financial Performance and Corporate Structure Insights of Jehangir Clinical Developement Centre.
Jehangir Clinical Developement Centre Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 68.71% increase. The company also saw a substantial improvement in profitability, with a 56.14% increase in profit. The company's net worth Soared by an impressive increase of 25.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jehangir Clinical Developement Centre?
In 2022, Jehangir Clinical Developement Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Linq Therapeutics Private LimitedActive 9 years 2 monthsJehangir Jehangir, Uma Divate and 3 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 Apr 2022 | ₹3.75 Cr | Open |
How Many Employees Work at Jehangir Clinical Developement Centre?
Unlock and access historical data on people associated with Jehangir Clinical Developement Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jehangir Clinical Developement Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jehangir Clinical Developement Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
